Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC   US23254L3069

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
2.83(c) 0.6798(c) 0.7397(c) 0.72(c) 0.6835(c) Last
80 377 5 385 087 1 313 055 576 678 493 658 Volume
-3.74% -75.98% +8.81% -2.66% -5.07% Change
More quotes
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company.It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases.Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
More about the company
Surperformance© ratings of Cyclacel Pharmaceuticals I
Trading Rating : - Investor Rating :
More Ratings
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1,28 M
EBIT 2014 -23,5 M
Net income 2014 -20,9 M
Debt 2014 -
Yield 2014 -
Sales 2015 0,25 M
EBIT 2015 -26,8 M
Net income 2015 -25,2 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 12,3x
Capi. / Sales 2015 62,8x
Capitalization 15,7 M
More Financials
Latest news on CYCLACEL PHARMACEUTICALS I
4d ago CYCLACEL PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form..
4d ago Cyclacel Announces Enrollment of 486 Patients, DSMB Recommendations and That ..
12/04 CYCLACEL PHARMACEUTICALS : Other Events (form 8-K)
11/12 CYCLACEL PHARMACEUTICALS : Management's Discussion and Analysis of Financial Con..
11/12 CYCLACEL PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
11/11 CYCLACEL PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results
11/04 CYCLACEL PHARMACEUTICALS : to Release 2014 Third Quarter Financial Results
10/09 CYCLACEL PHARMACEUTICALS : Announces Data Safety Monitoring Board Recommendation..
More news
Sector news
1d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
1d ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
1d ago ALNYLAM PHARMACEUTICALS : Announces Planned Departure of Chief Business Officer,..
More sector news


Comments 
Advertisement
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF